Hilar cholangiocarcinoma: current management.

Area of Science:

• Hepatobiliary Surgery
• Surgical Oncology
• Gastroenterology

Background:

• Hilar cholangiocarcinoma (Klatskin tumor) is a rare malignancy with a poor prognosis.
• Surgical resection offers the sole curative potential for this disease.
• Recent advancements in imaging and surgical techniques have improved patient outcomes.

Purpose of the Study:

• To comprehensively review the existing literature on the surgical management of hilar cholangiocarcinoma.
• To analyze outcomes, prognostic variables, and future directions in treating this complex cancer.

Main Methods:

• Systematic review of English-language literature published between 1990 and 2007.
• Inclusion of studies focusing on preoperative evaluation, surgical techniques, and management controversies.
• Analysis of prognostic factors and future research considerations.

Main Results:

• Complete surgical resection is the most effective curative therapy for hilar cholangiocarcinoma.
• Negative resection margins and major hepatic resections are linked to better outcomes.
• Portal vein embolization and staging laparoscopy are valuable adjuncts, and liver transplantation is an option for select cases.

Conclusions:

• Major hepatic resection remains the cornerstone of hilar cholangiocarcinoma treatment.
• Further research is required to establish the role of orthotopic liver transplantation.
• Enhancements in adjuvant therapies are crucial for improving long-term survival rates.